YouScript is excited to announce the next PGxperts™ Bytes - a series of short discussions covering important topics across the pharmacogenomics space. Host Joel Diamond, CMO of Aranscia, and guest Houda…
Read More
YouScript is excited to announce the next PGxperts™ Bytes - a series of short discussions covering important topics across the pharmacogenomics space. Host Houda Hachad, Vice President of Clinical Operations…
Read More
YouScript is excited to announce the next PGxperts™ Bytes - a series of short discussions covering important topics across the pharmacogenomics space. Host Joel Diamond, CMO of Aranscia®, and Houda…
Read More
YouScript is excited to announce the next PGxperts™ Bytes - a series of short discussions covering important topics across the pharmacogenomics space. Host Joel Diamond, CMO of Aranscia®, and Houda…
Read More
Aranscia® solutions help oncologists comply with new FDA warning label requiring DPYD genetic testing in patients receiving select chemotherapies HOUSTON, Oct. 16, 2025 /PRNewswire/ -- Oncologists and pharmacy experts are reacting to last…
Read More
Polypharmacy, adverse drug events, the Beers Criteria, and pain management. “Personalized prescribing in long-term care: Why it matters more than ever,” by Joel Diamond, CMO of YouScript's Partner, AccessDx Laboratory, in McKnight’s…
Read More
YouScript is excited to announce the next PGxperts™ Bytes - a series of short discussions covering important topics across the pharmacogenomics space. Host Kristine Ashcraft, President and Founder of YouScript,…
Read More
Prestigious International Annual Awards Program Recognizes Standout Digital Health & Medical Technology Products and Companies SEATTLE, WA – May 8, 2025 – YouScript®, an Aranscia company, today announced that it…
Read More
"Patients with DPYD variations are 25.6X more likely to experience treatment related death on standard‐dose fluoropyrimidine chemotherapy (5‐fluorouracil or capecitabine)." - Kristine Ashcraft, President and Founder of YouScript Read more about…
Read More
“Greater than 99% of people have at least one variation that impacts, on average, over 10 commonly prescribed medications that a patient will take,” said Kristine Ashcraft, the President and…
Read More
